Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
762.980.17%
QQQ
722.050.08%
BTC/USD
80479.690.9194%
DIA
516.150.05%
GLD
401.490.08%
TLT
81.260.01%

Anavex Life Sciences Corp (AVXL) Stock Price, Quote, News & History

AVXLNASDAQ
Trade with Public
Trade with Public
$2.42
0.010.41%
At close: Sep 18, 5:00 PM EST
$2.42
N/A
After Hours: Sep 18, 4:02 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Anavex Life Sciences (AVXL) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$2.42
Close
$2.42
Volume / Avg.
920.59K / 1.06M
Day Range
$2.38 - $2.45
52 Wk Range
2.26 - 10.38
Market Cap
$224.33M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
34
Short Interest
15.61%
Days to Cover
16.66

Recent Anavex Life Sciences Corp News

Crude Oil Moves Lower; Cintas Raises FY2026 Forecast

The Dow Jones index gained over 300 points, with the S&P 500 and NASDAQ also rising. Cintas Corp posted strong earnings and raised its forecast, while Sarepta Therapeutics and Braze Inc saw significant gains.
Avi Kapoor

Dow Surges Over 300 Points; Chewy Shares Jump On Upbeat Earnings

US stocks rise with the Dow gaining over 300 points. Chewy shares jump 14%. Sarepta Therapeutics surges 29%. Oil down 2.1%, gold up 3.2%.
Avi Kapoor

Anavex Life Sciences Stock Crushed As European Alzheimer's Drug Filing Pulled After EMA Pushback

Anavex shares fall after pulling EU filing for blarcamesine in Alzheimer's; EMA feedback prompts more data work.
Vandana Singh

Anavex Life Lead Drug Targets Early Alzheimer's Cause - New Study Highlights

New study links early brain cleanup failure to Alzheimer's, supporting Anavex Life drug approach targeting disease before plaques form.
Vandana Singh

What's Going On With Anavex Life Sciences Stock On Wednesday?

Anavex Life Sciences' stock rises despite no news, up over 40% this year as investors watch Alzheimer's program updates and analyst targets.
Vandana Singh

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-29.29M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
46.45M
Free Cash Flow (TTM)
-29.29M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
17.16M

Analyst Trends and Forecast

3
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$104.15M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.99
Earnings Yield % (TTM)
-5.81%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.21

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$118.33M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.42
Close
$2.42
Volume / Avg.
920.59K / 1.06M
Day Range
$2.38 - $2.45
52 Wk Range
2.26 - 10.38
Market Cap
$224.33M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
34
Short Interest
15.61%
Days to Cover
16.66

About

Sector
Health Care
Industry
Biotechnology
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data fr...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Anavex Life Sciences (AVXL) stock?

A

You can purchase shares of Anavex Life Sciences (NASDAQ:AVXL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Anavex Life Sciences (AVXL) competitors?

Q

What is the forecast, or price target, for Anavex Life Sciences (AVXL) stock?

A

Anavex Life Sciences has a consensus price target of $30.00.

Q

What is the current price for Anavex Life Sciences (AVXL)?

A

The stock price for Anavex Life Sciences (NASDAQ: AVXL) is $2.42 last updated September 18, 2026 at 4:02 PM EDT.

Q

Does Anavex Life Sciences (AVXL) pay a dividend?

A

There are no upcoming dividends for Anavex Life Sciences.

Q

When is Anavex Life Sciences (NASDAQ:AVXL) reporting earnings?

A

Anavex Life Sciences does not have any upcoming earnings scheduled.

Q

Is Anavex Life Sciences (AVXL) going to split?

A

There is no upcoming split for Anavex Life Sciences.

Q

What sector and industry does Anavex Life Sciences (AVXL) operate in?

A

Anavex Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved